< Back to the list of products
BRONCHI-SHIELD, Lyophilisate and solvent for suspension for nasal drops for dogs
- Provides active immunisation in dogs of 8 weeks of age or older to reduce coughing caused by Bordetella bronchiseptica
- Simple administration.
- Early protection for young puppies.
- Complements protection conferred by Duramune.
- Protects dogs for a full year.
- Can be administered to dogs over 15 kg via one nostril.
- Immunity is conferred from 5 days following vaccination.
Description
Each dose comprises:
Freeze-dried fraction (Lyophilisate)
| Active Substances: | |
|---|---|
| Bordetella bronchiseptica, live, strain 92B (*) CFU : colony forming unit | 2.1 x 106 to 5.5 x 108 CFU(*) |
| Solvent: | |
| Water for injections | ad 1 ml |
INDICATIONS
For active immunisation of dogs of 8 weeks of age or older to reduce coughing caused by Bordetella bronchiseptica.
Duration of immunity: 1 year.
Onset of immunity: from 5 days after vaccination
CONTRAINDICATIONS
Do not vaccinate sick/unhealthy animals.
Do not vaccinate animals undergoing antibacterial or immunosuppressive treatment.
ADVERSE REACTIONS
Occasionally, transient coughing (1 or 2 days) may occur, during the first days following vaccination.
In rare occasions, transient nasal or ocular discharge may be observed.
In animals, which show more severe signs, appropriate antibiotic treatment may be indicated.
However, veterinarians should be aware that antibiotic treatment given less than 14 days after
vaccination may impair vaccine efficacy.
Hypersensitivity reactions may occur. In case of anaphylactic reaction, administer adrenaline.
TARGET SPECIES
Dogs.
DOSAGE, ROUTE AND METHOD OF ADMINISTRATION
The vaccine is to be administered by nasal drops to dogs of the age of 8 weeks and older.
Aseptically reconstitute the lyophilisate with the solvent.
Shake the product well after reconstitution. Withdraw the liquid with the syringe, remove the
needle and replace with the applicator. The vaccine should be used immediately.
The head of the dog should be held with the nose pointing upwards and its mouth closed, so
that it is forced to breath through its nostrils. Administer the product in the nostrils drop by
drop.
Primary vaccination:
Vaccination with 1 dose of 1ml per dog from the age of 8 weeks.
Administer 0.5ml of vaccine in each nostril. For larger animals (>15 kg), 1.0 ml may be
administered in a single nostril.
One dose at least five days before the period of anticipated risk, e.g. temporary kennelling.
Booster:
Annual booster of one dose.
ADVICE ON CORRECT ADMINISTRATION
Disinfect hands and equipment after use.
WITHDRAWAL PERIOD
Not applicable.
SHELF LIFE
Shelf life of the veterinary medicinal product as packaged for sale: 24 months.
Shelf life after reconstitution according to directions: 8 hours.
SPECIAL STORAGE PRECAUTIONS
Store and transport refrigerated (+2°C to +8°C).
Do not freeze.
Protect from light.
SPECIAL WARNINGS
The product contains live bacteria and must be administered by the intranasal route only.
Parenteral administration can generate abscesses and cellulitis.
If any antibiotic is used within 2 weeks after vaccination, vaccination should be repeated after
completion of the antibiotic treatment.
Special precautions for use in animals
- Vaccinated dogs may excrete the vaccine strain of Bordetella bronchiseptica up to 7 weeks following vaccination. During this time, immunodepressed persons are advised to avoid contact with vaccinated dogs. Similar precautions are also applicable to unvaccinated in-contact or immunodepressed animals.
- The vaccine has been shown to be safe in pigs. Cats and unvaccinated dogs in contact with vaccinated dogs may react to the vaccine strain, presenting moderate clinical signs such as sneezing, nasal and ocular discharge. Other animals, such as rabbits and small rodents, have not been tested.
- Special precautions should be taken to avoid spreading of the vaccine strain in the clinic.
- In case of accidental self-injection during reconstitution of the product or inhalation of the aerosolized product at the time of application in the dog nostrils, seek medical advice immediately and show the package leaflet or the label to the physician.
- Persons administering the product to the dog should be aware that repeated exposure to the product by inhalation of aerosolized product may lead to rare hypersensitivity reactions.
- Although the risk that immunocompromised humans become infected with Bordetella bronchiseptica is extremely low, such individuals should be aware that dogs can shed the organism for up to 7 weeks after vaccination. Immunocompromised persons are advised to avoid contact with the vaccine and vaccinated dogs during the shedding period.
Do not use immunodepressing agents within 1 month of vaccination with the product.
No information is available on the safety and efficacy from the concurrent use of this vaccine with any other. It is therefore recommended that no other vaccines should be administered within 14 days before or after vaccination with this product.
Do not administer antibiotics during 14 days following vaccination.
Do not mix with any other vaccine or immunological product.
Dispose of waste materials by boiling, incineration or immersion in an appropriate disinfectant in accordance with national requirements.
OTHER INFORMATION
ATCv Code: QI07AE01
Nature and composition of immediate packaging
Freeze-dried Fraction:
Vial : Type I glass vial
Closure : Bromobutyl rubber stopper sealed with aluminum cap
Solvent
Vial : Type I glass vial
Closure : Bromobutyl stopper sealed with aluminum cap
Presentations
Box containing 10 vials of 1 dose of lyophilisate and 10 vials of 1 dose of solvent and 10 cannulae for application
